Konci Rea, Caminsky Natasha, Tulandi Togas, Dahan Michael H
Faculty of Medicine, McGill University, Montréal, QC.
Faculty of Medicine, McGill University, Montréal, QC; Department of Obstetrics and Gynecology, McGill University Health Centre, Montréal, QC.
J Obstet Gynaecol Can. 2020 Aug;42(8):984-1000. doi: 10.1016/j.jogc.2019.09.008. Epub 2019 Dec 24.
Intrauterine adhesions (IUAs) are a result of trauma to the basalis layer of the endometrium and may lead to clinical sequelae such as miscarriage, infertility, and menstrual irregularities. Hysteroscopy is recognized as the gold standard in diagnosis and management, although the optimal treatment after surgical intervention remains unclear. This review aimed to provide an update on the treatment options available after hysteroscopic adhesiolysis and to facilitate clinical management of patients with IUAs. To avoid duplicating previous work, the review focused on studies that compared various adjunctive postoperative treatments in patients receiving hormone therapy. Of 548 studies, 15 papers fit our criteria that compared post-resection treatment options in women with IUAs. Meta-analysis of the use of Foley catheter or amnion graft as an adjunctive therapy after adhesiolysis failed to show a statistical difference (odds ratio 1.55; 95% confidence interval 0.60-3.99). Meta-analysis could not be done for the 13 remaining studies as a result of extensive heterogeneity, bias, or non-comparable end points. The lack of a universal classification system for IUAs and the use of variable outcomes to measure the success of adjunctive treatment pose challenges in generating standard treatment recommendations. This review calls for the development of a universal classification system and studies with consistent parameters and end points to allow for the generation of standard treatment guidelines. On the basis of the available evidence, recommendation of specific adjunctive treatments after hysteroscopic adhesiolysis is unjustified.
宫腔粘连(IUAs)是子宫内膜基底层受到创伤的结果,可能导致流产、不孕和月经不调等临床后遗症。宫腔镜检查被认为是诊断和治疗的金标准,尽管手术干预后的最佳治疗方法仍不明确。本综述旨在更新宫腔镜粘连松解术后可用的治疗选择,并促进宫腔粘连患者的临床管理。为避免重复以前的工作,本综述重点关注比较接受激素治疗患者的各种辅助术后治疗的研究。在548项研究中,有15篇论文符合我们的标准,这些论文比较了宫腔粘连女性切除术后的治疗选择。对粘连松解术后使用Foley导管或羊膜移植作为辅助治疗的荟萃分析未能显示出统计学差异(优势比1.55;95%置信区间0.60-3.99)。由于广泛的异质性、偏倚或不可比的终点,其余13项研究无法进行荟萃分析。缺乏宫腔粘连的通用分类系统以及使用可变结果来衡量辅助治疗的成功,给制定标准治疗建议带来了挑战。本综述呼吁开发通用分类系统,并开展具有一致参数和终点的研究,以便制定标准治疗指南。根据现有证据,宫腔镜粘连松解术后推荐特定的辅助治疗是不合理的。